סימבקסון 40

देश: इसराइल

भाषा: हिब्रू

स्रोत: Ministry of Health

सक्रिय संघटक:

SIMVASTATIN

थमां उपलब्ध:

DEXCEL PHARMA TECHNOLOGIES LTD

ए.टी.सी कोड:

C10AA01

फार्मास्यूटिकल फॉर्म:

קפליות

रचना:

SIMVASTATIN 40 MG

प्रशासन का मार्ग:

פומי

प्रिस्क्रिप्शन प्रकार:

מרשם נדרש

द्वारा बनाया गया:

DEXCEL LTD, ISRAEL

चिकित्सीय समूह:

SIMVASTATIN

चिकित्सीय क्षेत्र:

SIMVASTATIN

चिकित्सीय संकेत:

Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia Simvaxon is indicated to: - Reduce the risk of total mortality by reducing coronary death - Reduce the risk of non-fatal myocardial infarction - Reduce the risk for undergoing myocardial revascularization procedures - Reduce the risk of stroke and transient ischemic attacks (TIA's). Hyperlipidemia: Simvaxon is indicated as an adjunct to diet to reduce elevated TOTAL-C LDL-C Apo B and TG and to increase HDL-C in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvaxon therefore lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia: Simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hype

उत्पाद समीक्षा:

Atorvastatin, Cerivastatin, Fluvastatin, Lovastatin, Pravastatin, Simvastatin

प्राधिकरण की तारीख:

2020-04-30